Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2022-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2021年年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled as "财务报表及审计报告 2021 年 12 月 31 日止年度" which translates to "Financial Statements and Audit Report for the year ended December 31, 2021." It contains detailed financial statements including consolidated and company balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. It also includes a detailed audit report with auditor opinions, audit basis, key audit matters, and responsibilities of management and auditors. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. The content is comprehensive and includes actual financial data and audit opinions, which matches the definition of an Annual Report (10-K) or an Audit Report (AR). However, the document is specifically titled as "审计报告" (Audit Report) and includes the auditor's opinion and detailed audit procedures, which is characteristic of an Audit Report / Information filing rather than a full Annual Report. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2021
2022-04-26 Chinese
监事会关于公司内部控制自我评价报告的核查意见
Regulatory Filings Classification · 95% confidence The document is a supervisory board's opinion on the company's internal control self-evaluation report for the year 2021. It references relevant laws and regulations and states that the supervisory board has reviewed the internal control self-evaluation report and provides their opinion. The document is short (476 characters) and serves as an announcement or opinion on the internal control report rather than the report itself. It does not contain detailed financial data or the full report. Therefore, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2022-04-26 Chinese
关于2021年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public offering by 康泰医学系统（秦皇岛）股份有限公司. It includes specifics on the amount raised, timing, usage, changes in project implementation, and compliance with regulatory requirements. The document references the Chinese Securities Regulatory Commission approval and includes detailed financial figures related to the raised funds. It is titled as a "专项报告" (special report) on the use and storage of raised funds for the fiscal year 2021. This type of document is typically classified as a Capital/Financing Update (CAP) because it focuses on fundraising activities, the use of proceeds, and related financial management rather than being a full annual report or earnings release. The length and detail confirm it is a substantive report, not just an announcement or certification. Therefore, the appropriate classification is CAP.
2022-04-26 Chinese
《董事会议事规则》
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Rules of Procedure for the Board of Directors" of 康泰医学系统（秦皇岛）股份有限公司. The content details the responsibilities, organization, meeting procedures, duties, and powers of the board of directors, including rules on meetings, proposals, voting, and execution of board resolutions. It is a governance document outlining internal rules and practices for the board rather than a financial report, announcement, or other regulatory filing. There is no indication of financial data, audit results, voting results, or management changes. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-04-26 Chinese
独立董事关于第三届董事会第十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various matters discussed at the 17th meeting of the third board of directors of 康泰医学系统（秦皇岛）股份有限公司. It covers opinions on the reappointment of the audit firm, internal control self-evaluation report, profit distribution plan, use of raised funds, director and senior management remuneration, election of an independent director, and use of excess raised funds. The document is a formal statement of independent directors' views on board meeting agenda items, not a full financial report or audit report itself. It is related to board/management information and governance matters but primarily focuses on independent directors' opinions on board meeting items. It is not an annual report, audit report, earnings release, or regulatory filing. Given the content and nature, the best fitting category is Board/Management Information (MANG). The document length is 2283 characters, which is relatively short and consistent with a board opinion statement rather than a full report.
2022-04-26 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 17th meeting of the 3rd Board of Directors of 康泰医学系统（秦皇岛）股份有限公司. It includes approvals of the 2021 Annual Report, audit reports, financial statements, internal control reports, profit distribution plans, appointment of independent directors, amendments to company bylaws, and other governance matters. The document repeatedly states that these resolutions will be submitted to the shareholders' meeting for approval. It also references the full 2021 Annual Report and audit reports being published elsewhere (on the official disclosure website), indicating this document is not the report itself but a board meeting resolution announcement. The content focuses on board decisions and governance issues rather than the full annual report or financial statements themselves. Therefore, this document fits best under the category of Board/Management Information (MANG), as it announces board meeting resolutions and management decisions.
2022-04-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.